North American Pharmacist Licensure Examination Absolute Failures Warrant Monitoring of Colleges and Schools of Pharmacy

John M. Pezzuto,Natalia Shcherbakova,Kimberly A. Pesaturo

DOI: https://doi.org/10.1101/2024.04.09.24305491

2024-04-10

Abstract:Over the past three years, 7,978 graduates of pharmacy programs have failed the North American Pharmacist Licensure Examination (NAPLEX) on the first attempt. At present, the ACPE monitors programs with a passage rate of ≥2 standard deviations (SD) below the national mean pass rate. In 2023, this would lead to monitoring seven programs that produced 140 failures out of the total of 2,472 failures (i.e., 5.7%). In our view, this is neither equitable nor demonstrative of sufficient accountability. Analysis of failure counts among the 144 programs reported by NABP demonstrates a distribution curve highly skewed to the right. After evaluating average failure counts across all the programs, we suggest that schools with absolute failures ≥2 SD higher than the average number of failures of all programs should be flagged for monitoring. Based on the 2023 data, this corresponds to ≥35 failures/program. This threshold would flag 18 programs and 36.5% of the total failures. Of the seven programs that will be monitored based on the current Accreditation Council for Pharmacy Education criteria, only one would be captured by the ≥35 failure method of selection with the remaining six contributing only 85 total failures to the pool. Thus, if both criteria were to be applied, i.e., ≥35 failures and of ≥2 standard deviations below the national mean pass rate, a total of 24 programs would be monitored (16.6% of the 144 programs), that contribute 987 (39.9%) of the total failures.

Medical Education

What problem does this paper attempt to address?

The focus of this paper is the proportion of pharmacy graduates in North America who fail their first attempt at the North American Pharmacist Licensure Examination (NAPLEX), and how this reflects the teaching quality of colleges and schools. Currently, the Accreditation Council for Pharmacy Education (ACPE) only monitors programs with pass rates that are more than 2 standard deviations below the national average pass rate. The authors of the paper argue that this standard is unfair and inadequate for accountability. They propose that monitoring standards should be set based on the absolute number of failures for each program, such that when the number of failures for a program exceeds 2 standard deviations above the mean failure rate for all programs, it should be flagged for monitoring. Based on this new standard, the data for 2023 would result in 18 programs being flagged, accounting for 36.5% of the total number of failures, whereas the current ACPE standard would only flag 7 programs. The paper emphasizes the importance of improving the pass rate for licensure examinations and suggests reconsidering the monitoring boundaries based on NAPLEX pass rates.